mishonga mitsva yekenza yemapapu danho rechina

Danho rechina kenza yemapapu, inozivikanwawo sekenza yemapapu yemetastatic, inopa matambudziko makuru. Nekudaro, tsvakiridzo inoenderera mberi uye kufambira mberi kwesarudzo dzekurapa zvinopa tariro uye hupenyu hwakavandudzwa. Ichi chinyorwa chinoongorora zvezvino mishonga mitsva yekenza yemapapu danho rechina, inovhara marapirwo akanangana, immunotherapies, miedzo yekiriniki, uye nzira dzekuchengetedza dzinotsigira.Kunzwisisa Danho 4 Kenza yeMapapuChii Danho rechina reCancer yemapapu?Danho rechina kenza yemapapu inoreva kuti gomarara rapararira (metastasized) kubva mumapapu kuenda kune dzimwe nhengo dzemuviri, sehuropi, mapfupa, chiropa, kana adrenal glands. Iyi nhanho inoda nzira yekurapa yakakwana yekugadzirisa chirwere uye zviratidzo zvayo. Kuti uwane rumwe ruzivo uye kufambira mberi kwetsvakiridzo, shanya Shandong Baofa Cancer Research Institute.Zviratidzo zvinowanzoitikaZviratidzo zvechikamu chechina kenza yemapapu zvinosiyana zvichienderana nenzvimbo yemetastases, asi zvinogona kusanganisira: Chikosoro chinoramba chichirwadza Kurwadza kwechipfuva Kushaya kufema Kurema Kurwadza kwebhonzo Musoro kana pfari Kurapwa Kutsva Kwegomarara Repamapapu Danho rechinaTargeted TherapiesTargeted therapies mishonga inonangana nemajini chaiwo, mapuroteni, kana nharaunda yetishu inobatsira mukukura kwegomarara uye kurarama. Mishonga iyi yakagadzirirwa kunyatso kurwisa maseru egomarara, kuderedza kukuvadzwa kumaseru akajairwa. Mienzaniso inosanganisira: EGFR Inhibitors: Inoshandiswa kumakenza emapapu ane EGFR mutations. Mishonga yakajairika inosanganisira erlotinib, gefitinib, afatinib, uye osimertinib. ALK Inhibitors: Inoshandiswa kumakenza emapapu ane ALK gene rearrangements. Mienzaniso inosanganisira crizotinib, alectinib, ceritinib, uye brigatinib. BRAF Inhibitors: Dabrafenib uye trametinib zvinoshandiswa kugomarara remapapu neBRAF V600E mutations. RET Inhibitors: Selpercatinib uye pralsetinib anoshandiswa kugomarara remapapu ane RET fusions.Sarudzo yerapi yakanangwa inoenderana nechaiyo genetic mutations inowanikwa mubundu remurwere kuburikidza nekuongororwa kwemamolecular. Mishonga mitsva yekenza yemapapu danho rechina dziri kuramba dzichishanduka netsvakiridzo inoenderera mberi kubva kumasangano akaita seShandong Baofa Cancer Research Institute.ImmunotherapyImmunotherapy inosimudzira kuzvidzivirira kwemuviri kurwisa cancer. Inoshanda nekukurudzira immune system kuziva uye kurwisa cancer maseru.Marudzi akajairika eimmunotherapy anoshandiswa padanho rechina kenza yemapapu anosanganisira: Checkpoint Inhibitors: Mishonga iyi inovhara mapuroteni anodzivirira immune system kurwisa masero egomarara. Mienzaniso inosanganisira pembrolizumab, nivolumab, atezolizumab, uye durvalumab.Immunotherapy inogona kushandiswa yoga kana kusanganiswa nekemotherapy kana kurapa kwakananga. Kushanda kwayo kunosiyana pakati pevarwere, uye biomarkers sePD-L1 kutaura kunogona kubatsira kufanotaura mhinduro. Baofa Cancer Research Institute inobatikana zvikuru mukutsvaga marapirwo aya.ChemotherapyChemotherapy inoramba iri nzira yekurapa yakajairwa pachidanho chechina chegomarara remapapu, kunyanya kana marapiro akananga kana kuti immunotherapies asina kukodzera kana kuti amira kushanda. Inosanganisira kushandisa zvinodhaka kuuraya masero ekenza mumuviri wose.Common chemotherapy regimens zvinosanganisira: Platinum-based doublets (somuenzaniso, cisplatin kana carboplatin yakasanganiswa ne pemetrexed, gemcitabine, kana taxanes)Chemotherapy inogona kukonzera migumisiro, saka kutarisira kunotsigira kunokosha kuti utarise migumisiro iyi uye kuchengetedza hupenyu hwehupenyu. Clinical TrialsClinical miedzo itsvakurudzo zvidzidzo zvinoedza mishonga mitsva yekenza yemapapu danho rechina. Kutora chikamu mukuedza kwekiriniki kunogona kupa mukana wekucheka-kumucheto marapirwo asati awanikwa zvakanyanya. Mabhenefiti ekutora chikamu muzviedzo zvekiriniki: Kuwaniswa kwezvitsva zvekurapa Kubatsira kutsvagurudzo yegomarara Kunyatsotarisisa uye nehanya Varwere vanogona kutsvaga miedzo yekiriniki kuburikidza nezviwanikwa zvakaita seNational Cancer Institute (NCI) kana American Cancer Society. Funga kuongorora mikana yekiriniki yekuedza kuburikidza Shandong Baofa Cancer Research Institute.Supportive Care and Palliative CareManaging Symptoms uye Kuvandudza Unhu hweLifeSupportive care, inozivikanwawo sepalliative care, inotarisa pakubvisa zviratidzo uye kuvandudza hupenyu hwevarwere vane danho rechina rekenza yemapapu. Icho chikamu chakakosha chechirongwa chekurapa uye chinogona kupihwa pamwe chete nemamwe marapirwo. Zvikamu zvekutarisira zvinotsigira zvinosanganisira: Kutarisira marwadzo Tsigiro yekudya Kutsigira Kwepfungwa uye kwepfungwa Kurapa KwekufemaBasa reChikwata cheMultidisciplinary TeamA multidisciplinary timu yevashandi vehutano inogona kupa tarisiro yakazara kuvarwere vane danho rechina rekenza yemapapu. Chikwata ichi chinogona kusanganisira: Vanamazvikokota Pulmonologists Radiation oncologists Vanamukoti Palliative care nyanzvi Vanamukoti Vashandi vezvekugarisana kwevanhu Vanorarama neChikamu 4 Chegomarara Repamapapu: Tariro Nezviwanikwa Kugara Uine ruzivo uye Kutsvaga RutsigiroKurarama nechikamu chechina kenza yemapapu kunogona kunetsa, asi zvakakosha kuti ugare uchiziva nezve marapirwo angasarudzwa uye kutsvaga rutsigiro kubva kune varapi vezvehutano nevanochengeta mhuri nevanochengeta mhuri. ipai zviwanikwa zvakakosha kuvarwere nevachengeti, zvinosanganisira: American Lung Association Lung Cancer Research Foundation Cancer Research UK MhedzisoKunyange danho rechina regomarara remapapu richiramba riri kuongororwa kwakakomba, kufambira mberi mukurapa uye kutsigirwa kwerutsigiro kwakavandudza zvakanyanya mhedzisiro uye hupenyu hwevarwere. Kurapa kwakanangwa, immunotherapies, uye miedzo yekiriniki inopa mishonga mitsva yekenza yemapapu danho rechina uye tariro yeramangwana riri nani. Zvakakosha kushanda pamwe chete nechikwata chemarudzi akawanda kugadzira chirongwa chemunhu chekurapa chinogadzirisa zvinodiwa nemunhu uye zvinangwa. Shandong Baofa Cancer Research Institute inoramba yakazvipira kufambisira mberi munda kuburikidza netsvakiridzo yehunyanzvi uye nehanya netsitsi.